Temporal Trends in Outcomes after Out-of-Hospital Cardiac Arrests Witnessed by Emergency Medical Services in Japan: A Population-Based Study

2016 ◽  
Vol 20 (4) ◽  
pp. 477-484 ◽  
Author(s):  
Kentaro Kajino ◽  
Tetsuhisa Kitamura ◽  
Kosuke Kiyohara ◽  
Taku Iwami ◽  
Mohamud Daya ◽  
...  
2012 ◽  
Vol 18 (6) ◽  
pp. 834-841 ◽  
Author(s):  
Ajay Parsaik ◽  
Rickey Carter ◽  
Lucas Myers ◽  
Jennifer Geske ◽  
Steven Smith ◽  
...  

2009 ◽  
Vol 27 (2) ◽  
pp. 141-145 ◽  
Author(s):  
Opeolu Adeoye ◽  
Christopher Lindsell ◽  
Joseph Broderick ◽  
Kathy Alwell ◽  
Edward Jauch ◽  
...  

1999 ◽  
Vol 5 (4) ◽  
pp. 294-297 ◽  
Author(s):  
A. Suruda ◽  
D. D Vernon ◽  
J. Reading ◽  
L. Cook ◽  
P. Nechodom ◽  
...  

2007 ◽  
Vol 14 (5 Supplement 1) ◽  
pp. S159-S159
Author(s):  
O. Adeoye ◽  
D. Kleindorfer ◽  
C. Lindsell ◽  
K. Alwell ◽  
M. Flaherty ◽  
...  

2021 ◽  
Vol 38 (9) ◽  
pp. A2.1-A2
Author(s):  
Tom Quinn ◽  
Timothy Driscoll ◽  
Lucia Gavalova ◽  
Mary Halter ◽  
Chris P Gale ◽  
...  

BackgroundUse of the Pre-Hospital 12-lead Electrocardiogram (PHECG) is recommended in patients presenting to emergency medical services (EMS) with suspected acute coronary syndrome (ACS).ObjectivesTo investigate differences in mortality between those who did/did not receive PHECG.MethodsPopulation-based, linked cohort study using Myocardial Ischaemia National Audit Project (MINAP) data from 2010-2017.ResultsOf 330,713 patients, 263,420 (79.6%) had PHECG, 67,293 (20.3%) did not. 30-day mortality was 7.8% overall, 7.1% with PHECG vs 10.9% without PHECG (adjusted Odds Ratio [aOR] 0.772, 95% confidence interval [CI] 0.748-0.795, p<0.001). 1 year mortality was 16.1% overall, 14.2% with PHECG vs 23.2% without (aOR 0.692, 95% CI 0.676-0.708, p<0.001). 144,254 patients had ST segment elevation myocardial infarction (STEMI); 130,240 (90.2%) had PHECG, 30 day mortality 8.8% overall, 8.0% with PHECG vs 15.9% without (aOR 0.588, 95% CI 0.557-0.622, p<0.001), 1 year mortality 13.1% overall, 12.1% with PHECG vs 22.8% without (aOR 0.585, 95% CI 0.557-0.614, p<0.001). 186,459 patients had non-STEMI; 133,180 (71.4%) had PHECG. 30-day mortality 7.1% overall, 6.1% with PHECG vs 9.6% without (aOR 0.677, 95%CI 0.652-0.704, p<0.001), 1 year mortality 18.3% overall, 16.3% with PHECG vs 23.3% without (aOR 0.694, 95% CI 0.676-0.713, p<0.001). 110,571 STEMI patients received primary PCI, 103,741 (93.8%) had PHECG. 30 day mortality 5.4% overall, 5.3% with PHECG vs 7.0% without (aOR 0.739, 95% CI 0.667-0.829, p<0.001). 1 year mortality 8.5% overall, 8.4% with PHECG vs 9.8% without (aOR 0.833, 95% CI 0.762-0.911, p<0.001). 26,127 (18.1%) STEMI patients received no reperfusion; 19,873 (76%) had PHECG. Mortality at 30 days 22.1% overall, 21.3% with PHECG vs 24.7% without (aOR 0.911, 95% CI 0.847-0.980, p=0.013), 1 year mortality 32.2% overall, 30.9% with PHECG, 36.4% without (aOR 0.865, 95% CI 0.810-0.925, p<0.001).ConclusionPHECG was associated with lower mortality at 30 days and 1 year in both STEMI and non-STEMI patients.


Stroke ◽  
2018 ◽  
Vol 49 (12) ◽  
pp. 3078-3080 ◽  
Author(s):  
Janet E. Bray ◽  
Judith Finn ◽  
Peter Cameron ◽  
Karen Smith ◽  
Lahn Straney ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document